Phase II study of induction chemotherapy with paclitaxel, ifosfamide, and carboplatin (TIC) for patients with locally advanced squamous cell carcinoma of the head and neck

Cancer. 2003 Mar 15;97(6):1589; author reply 1590. doi: 10.1002/cncr.11194.
No abstract available

Publication types

  • Comment
  • Letter

MeSH terms

  • Antineoplastic Combined Chemotherapy Protocols / administration & dosage
  • Antineoplastic Combined Chemotherapy Protocols / adverse effects*
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
  • Carboplatin / administration & dosage
  • Carcinoma, Squamous Cell / drug therapy*
  • Carcinoma, Squamous Cell / surgery
  • Clinical Trials, Phase II as Topic
  • Data Interpretation, Statistical
  • Endpoint Determination
  • Head and Neck Neoplasms / drug therapy*
  • Head and Neck Neoplasms / surgery
  • Humans
  • Ifosfamide / administration & dosage
  • Mesna / administration & dosage
  • Neutropenia / chemically induced*
  • Paclitaxel / administration & dosage
  • Reproducibility of Results
  • Survival
  • Taxoids

Substances

  • Taxoids
  • Carboplatin
  • Mesna
  • Paclitaxel
  • Ifosfamide

Supplementary concepts

  • TIC protocol